Recorded Chinese product: 复方氨基酸注射液复方氨基酸注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

山梨醇配制而成的灭菌水溶液是一种在国家药监局注册认定的药品。该药品含有山梨醇配制而成的灭菌水溶液、由种氨基酸与山梨醇配制而成的灭菌水溶液-7795fca9等成分。

该药品关联的活性成分包括:山梨醇配制而成的灭菌水溶液、由种氨基酸与山梨醇配制而成的灭菌水溶液。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:哈药集团制药六厂Chinese legal name: 哈药集团制药六厂。

您可以探索含有相同成分的其他药品:山梨醇配制而成的灭菌水溶液-3adb03a4成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 复方氨基酸注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Manufacturers recorded for this product: 哈药集团制药六厂Chinese legal name: 哈药集团制药六厂.

Explore other medicines containing the same ingredient: 山梨醇配制而成的灭菌水溶液 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 复方氨基酸注射液Recorded Chinese product: 复方氨基酸注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 250ml:21.1g(总氨基酸)Recorded Chinese specification: 250ml:21.1g(总氨基酸)

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 哈药集团制药六厂Chinese legal name: 哈药集团制药六厂

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H23023000

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H23023000

Manufacturer

Chinese legal name: 哈药集团制药六厂

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H23023000

生产企业

哈药集团制药六厂

适应症

预防和治疗肝性脑病。肝病时肝性脑病急性期或表现期的静脉营养。

用法用量

1 5%,静脉滴注,一次250~500ml。|2 12%,静脉缓慢滴注,一次250ml,滴速每分钟20~30滴。

不良反应

如输注速度过快,可能出现不耐受。

禁忌

非肝原性的氨基酸代谢紊乱,肾功能衰竭伴非蛋白氮升高,酸中毒,水潴留,休克。

注意事项

1.应密切注意水,电解质和酸碱平衡,根据血清离子谱补充电解质。2.为支持输入氨基酸参与合成代谢,达到最好利用,能量物质(葡萄糖和脂肪)应同时输入。3.低钠血症或血清渗透压升高的病人输注要谨慎,过快的输注速率会引起不耐受以及肾脏氨基酸丢失所致的氨基酸失衡。4.对同时患有肾功能不全的病人,氨基酸的用量应该随血清尿素和肌肝的水平调整。5.氨基酸治疗并非用以取代经证实的治疗肝性脑病的方法,例如净化性治疗,使用乳果糖和/或肠道抗菌素杀菌。

贮藏

密封保存。

规格

250ml:21.1g(总氨基酸)

证据Evidence

  • 批准文号: 国药准字H23023000
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.